CAR-T Therapy Shows Promise for Treating Autoimmune Diseases in Preliminary Study

CAR-T therapy, initially used in a lupus patient, has shown promising results in treating other autoimmune diseases such as systemic sclerosis and inflammatory myositis. In a small study, 14 autoimmune patients treated with CAR-T therapy remained in complete remission without the need for immunosuppressive drugs. While these early results are encouraging, further research is needed to determine the reproducibility, long-term safety, and efficacy of CAR-T therapy in treating autoimmune diseases.